Abstract
The mechanism behind hormone dependent growth of breast cancer is presently not well understood. We show that the HES-1 protein level in the breast cancer cell lines T47D and MCF-7 is down regulated by 17β-estradiol treatment. This regulation could be reversed by addition of the anti-estrogens 4OH tamoxifen, raloxifen and Imperial Chemical Industries (ICI) 182,780. In T47D cells with inducible exogenous HES-1 expression, induced expression of HES-1 protein prevented the proliferative effect of 17β-estradiol and subsequent up regulation of proliferating cell nuclear antigen (PCNA). An inverse correlation between the HES-1 and PCNA protein levels respectively was found in colon cancer cell lines. These findings point to a potential role of HES-1 as a tumor suppressor in epithelial cells, and as a mediator of 17β-estradiols proliferative effect on breast cancer cells.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 5951-5953 |
| Number of pages | 3 |
| Journal | Oncogene |
| Volume | 19 |
| Issue number | 51 |
| DOIs | |
| State | Published - Nov 30 2000 |
Keywords
- 17β-estradiol
- Antiestrogen
- HES-1
- PCNA
- Proliferation
ASJC Scopus subject areas
- Molecular Biology
- Cancer Research
- Genetics
Fingerprint
Dive into the research topics of 'The Hairy and Enhancer of Split homologue-1 (HES-1) mediates the proliferative effect of 17β-estradiol on breast cancer cell lines'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS